Ajay Soni
Daiichi Sankyo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ajay Soni.
Bioorganic & Medicinal Chemistry Letters | 2013
Ajay Soni; Abdul Rehman; Keshav Naik; Sunanda G. Dastidar; M.S. Alam; Abhijit Ray; Tridib Chaira; Vanya Shah; Venkata Palle; Ian A. Cliffe; Viswajanani J. Sattigeri
A novel set of compounds containing a 4,5-dihydro-5-methylisoxazoline have been successfully designed as VLA-4 receptor antagonists. Compound (14p) had a high receptor binding affinity of 4 nM and also found to be metabolically stable in vitro.
Bioorganic & Medicinal Chemistry Letters | 2010
Abdul Rehman; Ajay Soni; Keshav Naik; Sreeji Nair; Venkata Palle; Sunanda G. Dastidar; Abhijit Ray; M.S. Alam; Mohammad Salman; Ian A. Cliffe; Viswajanani J. Sattigeri
A novel set of compounds with a 1,3-dioxolane ring which acts as a proline bioisostere have been successfully designed as VLA-4 receptor antagonists. Compounds (18e), (28j), and (35g) were shown to have high receptor affinities.
Synthetic Communications | 2011
Ajay Soni; Akhilesh Dutt; Viswajanani J. Sattigeri; Ian A. Cliffe
Abstract A new and efficient method for the demethylation of 6-membered aza-heterocyclic methyl ethers is described using lithium chloride and para-toluenesulfonic acid. This process is chemoselective for aza-heterocyclic methyl ethers in the presence of aryl methyl ethers.
Bioorganic & Medicinal Chemistry Letters | 2018
Jitendra Sattigeri; Malvika Garg; Pragya Bhateja; Ajay Soni; Abdul Rehman Abdul Rauf; Mahendrakumar Gupta; Mahesh Subhashrao Deshmukh; Tarun Jain; Nidhi Alekar; Tarani Kanta Barman; Paras Kumar Jha; Tridib Chaira; Ramesh B. Bambal; Dilip J. Upadhyay; Takahide Nishi
FimH is a type I fimbrial lectin located at the tip of type-1 pili of Gram-negative uropathogenic Escherichia coli (UPEC) guiding its ability to adhere and infect urothelial cells. Accordingly, blocking FimH with small molecule inhibitor is considered as a promising new therapeutic alternative to treat urinary tract infections caused by UPEC. Herein, we report that compounds having the S-glycosidic bond (thiomannosides) had improved metabolic stability and plasma exposures when dosed orally. Especially compound 5h showed the potential to inhibit biofilm formation and also to disrupt the preformed biofilm. And compound 5h showed prophylactic effect in UTI model in mice.
Bioorganic & Medicinal Chemistry Letters | 2005
Biswajit Das; Sonali Rudra; Ajay Yadav; Abhijit Ray; A.V.S. Raja Rao; Akella Satya Surya Visweswara Srinivas; Ajay Soni; Suman Saini; Shalini Shukla; Manisha Pandya; Pragya Bhateja; Sunita Malhotra; Tarun Mathur; Sudershan Arora; Ashok Rattan; Anita Mehta
Arkivoc | 2005
Viswajanani J. Sattigeri; Ajay Soni; Smita Singhal; Seema Khan; Manisha Pandya; Pragya Bhateja; Tarun Mathur; Ashok Rattan; Jag Mohan Khanna; Anita Mehta
Archive | 2006
Venkata P. Palle; Viswajanani J. Sattigeri; Mohammad Salman; Ajay Soni; Abhijit Ray; Sunanda G. Dastidar
Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry | 2006
Viswajanani J. Sattigeri; Ajay Soni; Lavleen K. Gupta; Abhijit Ray; Sharif Ahmad; Jang Bahadur Gupta; Mohammad Salman
Archive | 2017
Ajay Soni; Aditi Agarwal; Sangram Shesharao Deshmukh; Kedar P. Purnapatre; Shinji Marumoto
Archive | 2012
Viswajanani J. Sattigeri; Venkata P. Palle; Manoj Kumar Khera; Ranadheer Reddy; Manoj Kumar Tiwari; Ajay Soni; Abdul Rchnian Abdul Rauf; Sony Joseph; Arpita Musib; Sunanda G. Dastidar; Punit Kumar Srivastava